Is there a way to prevent long COVID? A new study in the United States found that taking metformin, an affordable first-line Type 2 diabetes drug, shortly after diagnosis of COVID-19 can reduce the risk of developing long COVID by about 41 percent.
The study was conducted by researchers from the University of Minnesota, and the paper was published in the international medical journal The Lancet Infectious Diseases in June.
Long COVID refers to persistent discomfort for weeks or months after being infected with COVID-19. Common symptoms include fatigue, shortness of breath, cognitive impairment, headache, chest pain, and joint pain, among others, which affect daily life.
Through remote recruitment, the researchers screened 1,126 participants who agreed to long-term follow-up. They were overweight and obese people aged 30 to 85, had symptoms of COVID-19 infection for fewer than seven days, tested positive for COVID within three days of trial enrollment, and […]
Read the Whole Article From the Source: www.theepochtimes.com
